Synopsys (SNPS) EPS (Weighted Average and Diluted) (2009 - 2026)

Synopsys has reported EPS (Weighted Average and Diluted) for 18 years, with the latest figure at $0.34 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 82.01% year-over-year to $0.34; the trailing twelve-month figure through Jan 2026 stood at $6.51 (down 51.96% YoY), and the FY2025 full-year result was $8.07, down 44.38% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.34, down from $2.46 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $7.05 in Q4 2024, with the low at $0.34 in Q1 2026.
• Historically, EPS (Weighted Average and Diluted) has averaged $2.18 across 5 years, with a median of $1.89 in 2022.
• Annual changes were most pronounced in 2024 — EPS (Weighted Average and Diluted) soared 214.73% — and 2026, when it slumped 82.01%.
• Synopsys' EPS (Weighted Average and Diluted) stood at $0.98 in 2022, then surged by 128.57% to $2.24 in 2023, then soared by 214.73% to $7.05 in 2024, then plunged by 65.11% to $2.46 in 2025, then plunged by 86.18% to $0.34 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.34 (Q1 2026), $2.46 (Q4 2025), and $1.5 (Q3 2025), per Business Quant data.